血清蛋白标志物预测新生儿坏死性小肠结肠炎手术时机的研究进展  

Research Advances in Serum Protein Markers for Predicting Surgical Management of Necrotizing Enterocolitis

作　　者：向潇 郭振华[1] 

机构地区：[1]重庆医科大学附属儿童医院普外新生儿外科,重庆

出　　处：《临床医学进展》2024年第12期885-892,共8页Advances in Clinical Medicine

摘　　要：新生儿坏死性小肠结肠炎(Necrotizing enterocolitis, NEC)是新生儿期常见的一种胃肠道疾病,通常根据患儿全身症状及相关辅助检查将NEC进行Bell分期(I期可疑NEC;II期确诊NEC;III期进展NEC)。当前,通过患儿临床表现、实验室检验及放射学辅助检查可以诊断NEC,但是对NEC的准确分期和手术时机的把握仍有一定的难度。血液学指标具有客观性、准确性和简便性,对外科NEC有较好的预测价值。Necrotizing enterocolitis (NEC) is a common gastrointestinal disease in the neonatal period, and it is usually staged according to the systemic symptoms of the child and the relevant auxiliary examinations (stage I suspected NEC, stage II diagnosed NEC, stage III progressive NEC). Currently, the diagnosis of NEC is based on the combination of clinical, laboratory and radiographic findings, but it is difficult for pediatric surgeon to accurately identify the staging of NEC and early surgical intervention. Hematologic indexes have objectivity, accuracy and simplicity, and have good predictive value for surgical NEC.

关 键 词：血清蛋白标志物 新生儿坏死性小肠结肠炎(NEC) 外科NEC 研究进展 

分 类 号：R72[医药卫生—儿科]